Stock 603392 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Equities

603392

CNE100004090

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
66.3 CNY -2.94% Intraday chart for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. -2.90% -11.75%
04-25 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-12 Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected' MT

ETFs positioned on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD ETF KraneShares MSCI All China Health Care Index UCITS ETF - USD
1.43% 0 M€ -12.22% -
VANECK CHINA GROWTH LEADERS ETF - USD ETF VanEck China Growth Leaders ETF - USD
0.93% 12 M€ -16.71% -
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY UCITS ETF - ACC - USD ETF Goldman Sachs ActiveBeta Emerging Markets Equity UCITS ETF - Acc - USD
0.10% 0 M€ +4.69%
ICBCCS S&P CHINA 500 UCITS ETF CLASS B - USD ETF ICBCCS S&P China 500 UCITS ETF Class B - USD
0.08% 35 M€ -5.85% -
BMO MSCI GENOMIC INNOVATION INDEX ETF - CAD ETF BMO MSCI Genomic Innovation Index ETF - CAD
0.07% 2 M€ -.--%
BMO MSCI INNOVATION INDEX ETF - CAD ETF BMO MSCI Innovation Index ETF - CAD
0.04% 7 M€ -.--% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (D) - EUR ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (D) - EUR
0.01% 0 M€ +8.01% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF - USD ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF - USD
0.01% 0 M€ +5.91% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (C) - EUR ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (C) - EUR
0.01% 0 M€ +8.81% -
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.00% 4 M€ -4.41% -
LEADERSHARES EQUITY SKEW ETF - USD ETF LeaderShares Equity Skew ETF - USD
0.00% 0 M€ +3.95% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.00% 0 M€ +8.70% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.00% 0 M€ +8.24% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.00% 0 M€ +5.63% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.00% 0 M€ +5.79% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF - Distributing - EUR
0.00% 0 M€ +2.80% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.00% 0 M€ +3.50% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 0 M€ +3.63% -
DEMOCRACY INTERNATIONAL FUND ETF - USD ETF Democracy International Fund ETF - USD
0.00% 0 M€ +4.81% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF Acc - EUR
0.00% 0 M€ +0.32% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF - Distributing - EUR
0.00% 0 M€ +0.50% -
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY ETF Nomura NEXT FUNDS Emerging Market Equity MSCI-EM (Unhedged) ETF - JPY
0.00% 0 M€ +14.50%

Company Profile

Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Company is also engaged in the sales of agent products. The in-vitro diagnostics include: enzyme-linked immunosorbent assay (ELISA) reagents, chemiluminescence reagents, biochemical reagents and quality control products. The in-vitro diagnostic instruments mainly include the automatic chemiluminescence immunoassay analyzer. The primary product of vaccine products is Hecolin used for hepatitis E. The agent products are in-vitro diagnostics and in-vitro diagnostic equipment from Bio-Rad Laboratories Inc in the U.S. and Diagast SAS in France.
Sector
Pharmaceuticals
Calendar
22/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
66.3 CNY
Average target price
70.4 CNY
Spread / Average Target
+6.19%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.75% 11.64B
CSL LIMITED Stock CSL Limited
-2.61% 89.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.55% 40.9B
BIOGEN INC. Stock Biogen Inc.
-14.40% 32.25B
UCB Stock UCB
+55.89% 25.14B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.96% 15.39B
INCYTE CORPORATION Stock Incyte Corporation
-15.50% 11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-41.29% 11.89B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.87% 9.03B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-3.16% 8.62B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 603392 Stock
  4. Funds and ETFs Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.